Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn-Reference-Cited by-同舟云学术

Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn

Published:2004-11 Issue:4 Volume:87 Page:225-232
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Daniels G.,Finning K.,Martin P.,Soothill P.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1423-0410.2004.00569.x/fullpdf

Reference67 articles.

1. Amniocentesis and chorionic villus sampling

2. Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial

3. Presence of fetal DNA in maternal plasma and serum

4. Fetal RhD genotyping from maternal plasma

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of free DNA for fetal RHD genotyping in the Rh negative pregnant patient—the time has come;American Journal of Obstetrics and Gynecology;2024-08

2. Antenatal RHD screening to guide antenatal anti-D immunoprophylaxis in non-immunized D– pregnant women;Immunohematology;2024-04-01

3. Prevalence and determinants of RH alloimmunization in Rh-negative women in teaching hospitals of Addis Ababa, Ethiopia: a hospital-based cross-sectional study;Frontiers in Global Women's Health;2023-08-14

4. Weak D type 42: Antigen density and risk of alloimmunization in the province of Québec;Vox Sanguinis;2022-03-17

5. Cost‐effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies;Transfusion;2022-02-16